5-HT3 receptor
6 drugs CNS
2
approved indications
6
Approved Drugs
6
Companies
6
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (6 companies)
✓ All 6 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (6 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
Fresenius Kabi 1 drug
LEGACY PHARMA 1 drug
CUMBERLAND 1 drug
By Therapeutic Area
Other 5 drugs
CNS 1 drugs
Drugs by Company PRO
Fresenius Kabi 1 drug
LEGACY PHARMA 1 drug
CUMBERLAND 1 drug
VIWIT PHARM 1 drug
PF PRISM CV 1 drug
Takeda 1 drug
By Therapeutic Area
Other 5 drugs
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, LOTRONEX, SANCUSO, VARENICLINE TARTRATE +1 more
CNS 1 drugs
TRINTELLIX
Indications Treated
Smoking CessationNauseaVomitingMajor Depressive DisorderIrritable Bowel SyndromeDiarrhea
All Drugs Targeting 5-HT3 receptor
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE | Fresenius Kabi | 2006 | 2 | |
| LOTRONEX | LEGACY PHARMA | 2000 | 2 | |
| SANCUSO | CUMBERLAND | 2008 | 2 | |
| VARENICLINE TARTRATE | VIWIT PHARM | 2021 | 1 | |
| CHANTIX | PF PRISM CV | 2006 | 1 | |
| TRINTELLIX | Takeda | 2013 | 1 | CNS |